Acer Therapeutics Inc (NASDAQ:ACER)
| 2.78 Delayed Data As of Oct 21 |  -0.03 / -1.07%Today’s Change | 1.08 Today|||52-Week Range 7.25 | -30.67% Year-to-Date |
Latest ACER News | Press Releases
No recent news for Acer Therapeutics Inc.
Today’s Trading
| Previous close | 2.80 |
| Today’s open | 2.85 |
| Day’s range | 2.75 - 2.88 |
| Volume | 32,745 |
| Average volume (3 months) | 372,606 |
| Market cap | $34.5M |
Data as of 3:58pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | -17.18% |
| Earnings growth (this year) | +35.57% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONCTOncternal Therapeuti... | -0.02 | -1.18% |
| LIFEaTyr Pharma Inc | -0.13 | -3.83% |
| CLRBCellectar Bioscience... | -0.02 | -1.63% |
| ADXSAdvaxis Inc | +0.05 | +10.93% |
Data as of 7:55pm ET, 10/21/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$29.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
